Search Results
Litton: The Promise of PARP Inhibitors
Litton: The Promise of PARP Inhibitors
Dr. Litton on the Impact of PARP Inhibitors in Breast Cancer
MBCC 2017: Multiple PARP inhibitors show promise in breast cancer treatment
Addressing the Role of PARP Inhibitors in Different Breast Cancer Settings
PARP Inhibitors Improve Outcomes, QOL in Breast Cancer
Refining the role of PARP inhibitors in targeted anticancer therapy
PARP Inhibition in Ovarian Cancer
Telazoparib vs physicians choice for patients with mBRCA1 breast cancer
Future Role of PARP Inhibition in BRCA+ Breast Cancer
PARP Inhibitors & Will They Improve Small Cell Lung Cancer?
PARP Inhibitors as a Single Drug Therapy or in Combination Setting?
